Citations
1 citation(s) found for "Upadhyay, Navneet".
Cost per remission for mirikizumab versus ustekinumab for moderately to severely active ulcerative colitis treatment from the United States commercial payer perspective
Gulati, Ankit, Kane, Sunanda V. , Creveling, Thomas, Bires, Nicholas, Fisher, Deborah A. , Chanan, Neha, Koushik, Amit Kumar, Upadhyay, Navneet , Gulati, Ankit, Mittal, Neha
Journal of Medical Economics | May 12, 2025 | Volume: 28 | Issue: 1 | Pages: 709-718
